廠家供應(yīng)原料藥達(dá)比加群酯 ,211915-06-9
英文名稱:N-[2-[4-[N-(Hexyloxycarbonyl)amidino]phenylaminomethyl]-1-methyl-1H-benzimidazol-5-ylcarbonyl]-N-(2-pyridyl)-beta-alanine ethyl ester
英文別名:Pradaxa; Dabigatran etexilate; BIBR-1048MS; BIBR-1048; ethyl N-[(2-{[(4-{[(hexyloxy)carbonyl]carbamimidoyl}phenyl)amino]methyl}-1-methyl-1H-benzimidazol-5-yl)carbonyl]-N-pyridin-2-yl-beta-alaninate; Alanine,N-[[2-[[[4-[[[(hexyloxy)carbonyl]amino]iminomethyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-,ethyl ester
CAS號(hào):211915-06-9
化學(xué)名稱:β-丙氨酸,N-[[2-[[[4-[[[(己氧基)羰基]氨基]亞氨基甲基]苯基]氨基]甲基]-1-甲基-1H-苯并咪唑-5-基]羰基]-N-2-嘧啶-,乙酯,甲磺酸鹽
分子量:723.86 (甲磺酸鹽)
627.75 (游離物)
廠家供應(yīng)原料藥達(dá)比加群酯 ,211915-06-9
預(yù)防存在以下一個(gè)或多個(gè)危險(xiǎn)因素的成人非瓣膜性房顫患者的卒中和全身性栓塞(SEE):
● 先前曾有卒中、短暫性腦缺血發(fā)作或全身性栓塞
● 左心室射血分?jǐn)?shù)<40%
●伴有癥狀的心力衰竭,紐約心臟病協(xié)會(huì)(NYHA)心功能分級(jí)≥2級(jí)
●年齡≥75歲
●年齡≥65歲,且伴有以下任一疾?。禾悄虿?、冠心病或高血壓
密度:1.24g/cm3
沸點(diǎn):827.9°C at 760 mmHg
閃點(diǎn):454.5°C